AzTrials
AzTrials

Obsessive ThoughtsGGRONCT03571464

Study of the Efficacy of GGRO: a Novel Cognitive Training App

A study testing GGRO Mobile App in people with Obsessive Thoughts, run by University of Valencia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the present study was to evaluate the efficacy of GGRO reducing OCD related maladaptive beliefs and OCD symptoms. Specifically, a randomized controlled trial with crossover design was carried out in non-clinical population to assess pre-post changes in levels of OCD-related maladaptive beliefs and OCD… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Obsessive Thoughts
What is being tested?
GGRO Mobile App
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
97 participants
Where
No sites listed yet
Study dates
25 Sep 2016to 25 Jul 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Being a Spanish at native level, and having a mobile device capable of installing the application GGRO

Who cannot join

  • None

About this study

Official title: Can Brief, Daily Training Using a Mobile Applications Help Change Maladaptive Beliefs? A Cross-over Randomized-control Study Evaluating the Efficacy of GGRO in Reducing Maladaptive Beliefs and Obsessive-compulsive Symptoms

The aim of the present study was to evaluate the efficacy of GGRO reducing OCD related maladaptive beliefs and OCD symptoms. Specifically, a randomized controlled trial with crossover design was carried out in non-clinical population to assess pre-post changes in levels of OCD-related maladaptive beliefs and OCD symptoms, including relationship OCD (ROCD) symptoms, self-esteem, and depressive symptoms following 15 days of using GGRO.

Read the detailed description

The implementation of Information and Communication Technologies in the treatment or prevention of OCD symptoms has been significantly lower compared to with its application in other anxiety disorders.

Recently, an exploratory study evaluated a brief, game-like, training exercise for challenging OCD-beliefs delivered via a mobile application platform named GGRO. However, more studies are needed to test the efficacy.

Being tested
GGRO Mobile App
Keywords
obsessive compulsive disorder, cognitive therapy, maladaptive beliefs, mobile app
Medical subject headings
Obsessive-Compulsive Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • GGRO Mobile AppDevice

    GGRO was designed to challenge maladaptive beliefs that underlie common OCD symptoms (e.g., contamination, repugnant thoughts) as well as relationships obsessions. Users are presented with 'blocks' featuring statements such as "I take things as they come" or "Everything can end in a catastrophe". Users then have to respond to these statements by either pulling 'blocks' towards themselves (i.e., downwards) or throwing the blocks away from themselves (i.e., rejecting them upwards).

Study groups in NCT03571464
Study groupRoleWhat they receive
Immediate use GGRO Mobile AppExperimentalThe group starts using the GGRO Mobile App immediately after the first assessment (T1) for 15 days.
Receives: Device: GGRO Mobile App
Delayed use GGRO Mobile AppActive comparatorDelayed use GGRO Mobile App group started using the App 15 days after the first assessment (T2).
Receives: Device: GGRO Mobile App

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in obsessive beliefs

    Score change in obsessive compulsive maladaptive beliefs measured by the short form of the Obsessive Beliefs Questionnaire (OBQ-20). Total score is computed as a mean of the 20 items, ranging from 1 "disagree very much" to 7 "agree very much". Higher scores indicate the person has more obsessive beliefs.

    Measured: 15 days

Secondary outcomes (3)
  1. Change in obsessive compulsive symptoms

    Score change in obsessive-compulsive symptoms measured by the Obsessive Compulsive Inventory- Revised version (OCI-R). Total score is computed as a mean of the 18 items, ranging from 0 "not at all" to 4 "Extremely". Higher scores indicate a greater presence of obsessive-compulsive symptoms.

    Measured: 15 days

  2. Change in depression symptoms

    Score change in depression symptoms measured by Depression, Anxiety and Stres Scale (DASS). The depression scale is composed by the mean of 7 items, ranging from 0 "did not apply to me at all" to 3 "applied to me very much, or most of the time". Higher scores indicate a greater presence of obsessive -compulsive symptoms.

    Measured: 15 days

  3. Change in Self-Esteem

    Change in score of Single Ítem Self Esteem Scale (SISE). Self-Esteem is measured with this single item ranging from 1 "not very true for me" to 9 "very true for me". Higher scores indicates a higher Self-Esteem.

    Measured: 15 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jun 2018
  2. Study start25 Sep 2016
  3. Primary completion10 Jun 2017
  4. Study completion25 Jul 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
All participants were requested to complete web-based assessment, with questionnaires relating to maladaptive beliefs, mood and OC symptoms at baseline (T1), 15 days following baseline (T2) and 30 days following baseline (T3). Participants in Immediate use GGRO group started using the app at baseline and continued using the app for 15 consecutive days. They were then requested to stop using the app until T3. Participants in the Delayed use GGRO group were requested to wait for 15 days and only then start using the app (cross-over) for 15 consecutive days.
Masking
None (open label)
Enrolment
97 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03571464
Sponsor's protocol ID
706208
Acronym
GGRO
Status last verified
Jun 2018
First submitted
12 Jun 2018
Last updated
29 Jun 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Roncero M, Belloch A, Doron G. A novel approach to challenging OCD related beliefs using a mobile-app: An exploratory study. J Behav Ther Exp Psychiatry. 2018 Jun;59:157-160. doi: 10.1016/j.jbtep.2018.01.008. Epub 2018 Feb 2.

    PubMed 29425951
  • Roncero M, Belloch A, Doron G. Can Brief, Daily Training Using a Mobile App Help Change Maladaptive Beliefs? Crossover Randomized Controlled Trial. JMIR Mhealth Uhealth. 2019 Feb 13;7(2):e11443. doi: 10.2196/11443.

    PubMed 30758294

Questions about this trial

What is this clinical trial studying?

A study testing GGRO Mobile App in people with Obsessive Thoughts, run by University of Valencia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jun 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in obsessive beliefs (time frame: 15 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03571464, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jun 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in